Picture of Humana AB logo

HUM Humana AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareAdventurousSmall CapSuper Stock

Sweden's Humana AB misses Q4 revenue estimates, announces dividend

Overview

Nordic care firm's Q4 revenue missed analyst expectations, with negative organic growth

Company acquired Familiehjelpgruppen in Norway, enhancing preventive care services

Board proposed a 35% dividend increase for 2025 financial year

Outlook

Humana plans growth projects worth approximately SEK 450 mln for 2026

Company aims to achieve net zero emissions by 2050

Humana plans new nursing home and LSS group home in Sollentuna by 2028

Result Drivers

ACQUISITION IMPACT - Acquisition of Familiehjelpgruppen in Norway strengthens preventive care offerings

CLIMATE TARGETS - Climate targets validated by SBTi, aiming for net zero emissions by 2050

PROJECT PIPELINE - Signed growth projects of approximately SEK 450 million to drive future growth

Key Details

MetricBeat/MissActualConsensus Estimate
Q4 RevenueMissSEK 2.48 blnSEK 2.56 bln (3 Analysts)
Q4 Net IncomeSEK 26 mln
Q4 Adjusted Operating ProfitSEK 87 mln
Q4 Operating ProfitSEK 83 mln
Q4 Organic Growth-1.90%
Analyst Coverage The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell" The average consensus recommendation for the healthcare facilities & services peer group is "buy" Wall Street's median 12-month price target for Humana AB is SEK60.00, about 20.6% above its February 5 closing price of SEK49.75 The stock recently traded at 8 times the next 12-month earnings vs. a P/E of 7 three months ago Press Release: ID:nMFN176drH For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com. (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Humana AB

See all news